Viewing Study NCT00170833


Ignite Creation Date: 2025-12-25 @ 3:00 AM
Ignite Modification Date: 2026-03-04 @ 10:43 PM
Study NCT ID: NCT00170833
Status: COMPLETED
Last Update Posted: 2011-11-02
First Post: 2005-09-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Tolerability and Efficacy of Everolimus With Lower Versus Higher Levels of Tacrolimus in de Novo Renal Transplant Patients
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Renal Transplantation View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Renal/Kidney, transplantation, everolimus, calcineurin sparing View